ASP Isotopes Files 10-Q, Reports on Q2 Performance

TL;DR

ASP Isotopes 10-Q filed: Q2 results in, common shares offered June 3rd.

AI Summary

ASP Isotopes Inc. filed its 10-Q for the period ending June 30, 2025. The company reported on its financial performance and operations, including details on sales revenue and various assets. Notably, the filing mentions a Registered Direct Offering of Common Shares on June 3, 2025, and references agreements like the AspRentals Shareholder Agreement from June 2024.

Why It Matters

This filing provides investors with a quarterly update on ASP Isotopes' financial health and strategic activities, including recent equity offerings.

Risk Assessment

Risk Level: medium — The filing details financial performance and equity offerings, which can indicate both growth opportunities and potential dilution or market volatility.

Key Numbers

• 2025-06-30 — Reporting Period End Date (The end date for the financial information presented in the 10-Q.)
• 2025-08-14 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
• 2025-06-03 — Registered Direct Offering Date (Date of a significant equity issuance event.)

Key Players & Entities

• ASP Isotopes Inc. (company) — Filer of the 10-Q
• 20250630 (date) — End of the reporting period
• 20250814 (date) — Filing date
• 601 PENNSYLVANIA AVENUE NW (address) — Company's business and mail address
• 2025-06-03 (date) — Date of Registered Direct Offering
• aspi:CommonShareMember (security) — Type of security offered
• aspi:AspRentalsShareholdersAgreementMember (agreement) — Mentioned agreement

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01per share ASPI The Nasdaq Stock Mark
• $30,000,000 — or at all; our inability to be repaid $30,000,000 advanced to Renergen under a loan agree
• $30 million — stors for a potential debt financing of $30 million aggregate principal amount in order to

Filing Documents

• aspi-20250630.htm (10-Q) — 3333KB
• aspi-ex10_1.htm (EX-10.1) — 703KB
• aspi-ex10_3.htm (EX-10.3) — 612KB
• aspi-ex10_4.htm (EX-10.4) — 623KB
• aspi-ex31_1.htm (EX-31.1) — 17KB
• aspi-ex31_2.htm (EX-31.2) — 19KB
• aspi-ex32_1.htm (EX-32.1) — 15KB
• 0000950170-25-108971.txt ( ) — 16625KB
• aspi-20250630.xsd (EX-101.SCH) — 1609KB
• aspi-20250630_htm.xml (XML) — 3238KB

Financial Statements (Unaudited)

Financial Statements (Unaudited) 5 Condensed Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024 5 Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Six Month Periods ended June 30, 2025 and 2024 6 Condensed Consolidated Statements of Changes in Stockholders' Equity for the Three and Six Month Periods ended June 30, 2025 and 2024 7 Condensed Consolidated Statements of Cash Flows for the Six Month Periods ended June 30, 2025 and 2024 8 Notes to Unaudited Condensed Consolidated Financial Statements 9 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 26 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 36 Item 4.

Controls and Procedures

Controls and Procedures 36 PART II. OTHER INFORMATION 37 Item 1.

Legal Proceedings

Legal Proceedings 37 Item 1A.

Risk Factors

Risk Factors 37 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 42 Item 3. Defaults Upon Senior Securities 42 Item 4. Mine Safety Disclosures 42 Item 5. Other Information 42 Item 6. Exhibits 43

Signatures

Signatures 44 2 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations and financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as "may," "should," "would," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this Quarterly Report on Form 10-Q are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q and are subject to a number of risks, uncertainties and assumptions described in the section titled "Risk Factors" and elsewhere in this Quarterly Report on Form 10-Q. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may no

-FIN ANCIAL INFORMATION

PART I-FIN ANCIAL INFORMATION

Finan cial Statements

Item 1. Finan cial Statements. ASP Isotopes Inc. Condensed Conso lidated Balance Sheets (unaudited) June 30, 2025 December 31, 2024 Assets Current assets: Cash and cash equivalents $ 67,679,097 $ 61,890,048 Accounts receivable 649,476 706,925 Inventory 1,045,612 65,655 Receivable from noncontrolling interests — 27,556 Note receivable 30,363,798 — Lease receivable - current 16,273 — Prepaid expenses and other current assets 1,834,245 3,053,478 Total current assets 101,588,501 65,743,662 Property and equipment, net 27,600,294 22,354,377 Operating lease right-of-use assets, net 1,016,560 1,122,134 Deferred tax assets 33,509 31,847 Goodwill 3,362,650 3,168,101 Lease receivable - noncurrent 376,314 — Other noncurrent assets 1,936,664 1,927,867 Total assets $ 135,914,492 $ 94,347,988 Liabilities and stockholders' equity Current liabilities: Accounts payable $ 2,600,670 $ 1,021,393 Accrued expenses 1,792,652 2,275,681 Notes payable - current 342,080 939,110 Finance lease liabilities – current 145,976 125,862 Operating lease liabilities – current 500,873 557,676 Deferred revenue 882,000 882,000 Other current liabilities 489,584 1,256,549 Share liability 149,766 — Total current liabilities 6,903,601 7,058,271 Convertible notes payable, at fair value 98,148,315 33,433,184 Notes payable - noncurrent 1,393,519 1,441,286 Finance lease liabilities – noncurrent 518,578 560,328 Operating lease liabilities – noncurrent 639,419 688,479 Total liabilities 107,603,432 43,181,548 Commitments and contingencies (Note 8) Stockholders' equity Preferred stock, $ 0.01 par value; 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2025 and December 31, 2024 — — Common stock, $ 0.01 par value; 500,000,000 shares authorized, 83,905,417 and 72,068,059 shares i

View Full Filing

View this 10-Q filing on SEC EDGAR